- Home
- RNAZ vs TWAV Comparison
RNAZ vs TWAV Comparison
Compare RNAZ & TWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNAZ | TWAV |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | N/A | 7 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6M | 5.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | RNAZ | TWAV |
|---|---|---|
| Price | $4.89 | $1.27 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 43.7K | ★ 1.8M |
| Earning Date | 04-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.82 | $0.58 |
| 52 Week High | $20.99 | $2.58 |
Technical Indicators
Market Signals| Indicator | RNAZ | TWAV |
|---|---|---|
| Relative Strength Index (RSI) | 30.39 | 36.93 |
| Support Level | $3.82 | $1.21 |
| Resistance Level | $6.15 | $1.86 |
| Average True Range (ATR) | 0.69 | 0.18 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 0.00 | 2.42 |
Price Performance
Historical ComparisonAbout RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
About TWAV TaoWeave Inc. Common Stock
TaoWeave Inc is a digital asset company. The company offers investors a regulated, publicly traded vehicle to gain exposure to the decentralized AI economy. The company aims to invest in the Bittensor ecosystem through partnerships with subnets, miners, and validators, and operates with zero debt by maintain appropriate cash reserves. The Company currently operates in three segments: (1) "Digital Assets", which represents the business surrounding treasury activity with Bittensor, (2) Collaboration Products which represents the business surrounding Mezzanine product offerings, and (3) Managed Services, which represents the business surrounding managed services for video collaboration and network solutions.